Genetic Susceptibility to Fungal Infections: What is in the Genes?
- 802 Downloads
The development of severe fungal infections has long been associated with traditional risk factors such as profound immunosuppression, yet it remains challenging to understand why under similar conditions, only some patients will develop these infections while others will not. Recent studies have demonstrated the importance of host genetic variation in influencing the severity and susceptibility to invasive fungal infections. In this review, we examine selected primary immunodeficiencies characterized by their vulnerability to a narrow range of fungal pathogens and then focus on recently identified genetic polymorphisms associated with an increased susceptibility to invasive fungal infections.
KeywordsGenetic susceptibility Single-nucleotide polymorphism Invasive Candida infection Invasive aspergillosis Cryptococcus
This work was supported by 5T32-AI052080-12 (SAM) and AI 73896, AI 04533, and AI 93257 (JRP) from the NIH.
All authors contributed to the literature review, writing, reading, and approving the manuscript.
Compliance with Ethical Standards
Conflict of Interest
Stacey Maskarinec reports grants from the National Institutes of Health, during the conduct of the study.
Melissa Johnson reports grants and personal fees from Astellas Pharma, grants from Charles River Laboratories, and personal fees from Up To Date, LLC outside the submitted work.
John Perfect reports grants from Astellas, other from Pfizer, grants from Merck, other from F2G, and grants from Scynexis during the conduct of the study.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 8.•Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M, et al. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest. 2013;123(12):5035–51. This study revealed the direct interaction of macrophages with fungus at the site of infection as well as showed that the dysfunctional CX3CR1 SNP is associated with susceptibility to infection in both mice and humans. Google Scholar
- 9.•Swamydas M, Gao JL, Break TJ, Johnson MD, Jaeger M, Rodriguez CA, et al. CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Sci Transl Med. 2016;8(322):322ra10. This study identified CXCR1 as a critical factor in innate host immune defense against systemic Candida infection in both mice and humans, and that variation in CXCR1 in humans is associated with impaired neutrophil effector function. Google Scholar
- 14.Casadevall A, Mitchell AP, Berman J, Kwon-Chung KJ, Perfect JR, Heitman J. Human fungal pathogens. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2015.Google Scholar
- 40.•Smeekens SP, Ng A, Kumar V, Johnson MD, Plantinga TS, van Diemen C, et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun. 2013;4:1342. By integrating transcriptional analysis and functional genomics, these authors demonstrated that the type I interferon pathway has a critical role in anti- Candida defense in humans. Google Scholar
- 48.Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol. 2003;41(1):90–6.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis. 2005;40(9):1258–62.CrossRefPubMedGoogle Scholar
- 59.Cunha C, Di Ianni M, Bozza S, Giovannini G, Zagarella S, Zelante T, et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood. 2010;116(24):5394–402.CrossRefPubMedGoogle Scholar
- 61.Mezger M, Steffens M, Beyer M, Manger C, Eberle J, Toliat MR, et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood. 2008;111(2):534–6.CrossRefPubMedGoogle Scholar
- 67.•Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med. 2014;370(5):421–32. Hematopoetic stem cell transplant recipients who received a donor with a homozygous haplotype in PTX3 were associated with an increased risk of invasive aspergillosis, which was linked to a deficiency in PTX3 and diminished anti-fungal capabilities of neutrophils. Google Scholar
- 71.•Koldehoff M, Beelen DW, Elmaagacli AH. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation. Transpl Infect Dis. 2013;15(5):533–9. This paper demonstrated an association between specific TLR4 haplotypes and the risk for invasive aspergillosis in recipients of hematopoietic stem cell transplants, implicating the need for optimized prevention and screening strategies in this population. Google Scholar
- 75.•Rohatgi S, Gohil S, Kuniholm MH, Schultz H, Dufaud C, Armour KL, et al. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease. MBio. 2013;4(5):e00573–13. This study demonstrated a significant association between the FCGR3A 158V allele and cryptococcal disease risk in HIV-infected individuals, which extends previous studies that show the same association in HIV-uninfected patients. Google Scholar
- 81.•Wojtowicz A, Tissot F, Lamoth F, Orasch C, Eggimann P, Siegemund M, et al. Polymorphisms in tumor necrosis factor-alpha increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients. Crit Care Med. 2014;42(4):e304–8. The authors identified that genetic variations in tumor necrosis factor-alpha are associated with susceptibility to intra-abdominal Candida infection in a cohort of high risk, non-neutropenic patients. Google Scholar
- 94.Centers for Disease Control and Prevention. C. neoformans infection statistics 2015. Available from: http://www.cdc.gov/fungal/diseases/cryptococcosis-neoformans/statistics.html.
- 96.Netea MG, Brouwer AE, Hoogendoorn EH, Van der Meer JW, Koolen M, Verweij PE, et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis. 2004;39(9):e83–7.CrossRefPubMedGoogle Scholar
- 98.Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. MBio. 2014;5(2):e00912–14.CrossRefPubMedPubMedCentralGoogle Scholar
- 99.Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499–508.CrossRefPubMedGoogle Scholar